Founded in 2011 and based in Dublin, Monitored Therapeutics Inc. is a telemedicine company specializing in respiratory monitoring devices. The remote patient management company started with its focus on software, but later grew to include a physical device to assist with monitoring patients.
Recently, MTI received its first institutional capital investment from the Columbus-based capital investment firm Tamarind Hill. With that, MTI will invest $650,000 to expand its headquarters in Dublin and add 35 new personnel, in IT, account management and clinical project management positions.
MTI plans to relocate to a new, 17,000-square-foot building in the same community as its existing location early next year, in a testament to the growing telemedicine field in Dublin.
The investment and move comes as the company experiences major growth, despite early challenges the pandemic brought on.
#
Media Contact:
Andrew Kohn
Public Affairs Officer
614.578.1302 – Cell
akohn@dublin.oh.us
Newsroom: https://dublinohiousa.gov/newsroom/
Comments are closed.